Quality of life of treatment for relapsed/refractory multiple myeloma: a systematic review

被引：0
|
作者：
Nassim, Maria [1 ]
Nilsson, Jonas [1 ]
Zavisic, Stojan [2 ]
Malmenas, Mia [1 ]
Fotheringham, Iain [3 ]
Purushotham, Sneha [3 ]
机构：
[1] ICON Plc, Stockholm, Sweden
[2] Oncopeptides, Stockholm, Sweden
[3] ICON Plc, London, England
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期
关键词：
Health related quality of life; Multiple myeloma; Quality of Life;
D O I：
10.1016/j.clml.2019.09.458
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SP-132
引用
收藏
页码：E278 / E278
页数：1
相关论文
共 50 条
  • [31] Thalidomide for the treatment of relapsed and refractory multiple myeloma
    Cool, RM
    Herrington, JD
    PHARMACOTHERAPY, 2002, 22 (08): : 1019 - 1028
  • [32] Patient-reported outcomes in relapsed/refractory multiple myeloma: a systematic review
    Francesco Sparano
    Michele Cavo
    Pasquale Niscola
    Tommaso Caravita
    Fabio Efficace
    Supportive Care in Cancer, 2018, 26 : 2075 - 2090
  • [33] Isatuximab for the treatment of relapsed/refractory multiple myeloma
    Richardson, Paul G.
    Beksac, Meral
    Spicka, Ivan
    Mikhael, Joseph
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (12) : 1395 - 1403
  • [34] Treatment options for relapsed and refractory multiple myeloma
    Nooka, Ajay K.
    Kastritis, Efstathios
    Dimopoulos, Meletios A.
    Lonial, Sagar
    BLOOD, 2015, 125 (20) : 3085 - 3099
  • [35] Efficacy of Selinexor Based Regimens in Relapsed Refractory Multiple Myeloma: A Systematic Review
    Khalid, Farhan
    Hashmi, Mydah Sajid
    Tayyeb, Muhammad
    Jaan, Ali
    Ahmed, Zahoor
    Dar, Abdul Jabbar
    Aamir, Sobia
    Khurshid, Qasim
    Kashyap, Richi
    Khan, Israr
    Rehman, Saif Ur
    Ehsan, Hamid
    Anwer, Faiz
    BLOOD, 2020, 136
  • [36] Patient-reported outcomes in relapsed/refractory multiple myeloma: a systematic review
    Sparano, Francesco
    Cavo, Michele
    Niscola, Pasquale
    Caravita, Tommaso
    Efficace, Fabio
    SUPPORTIVE CARE IN CANCER, 2018, 26 (07) : 2075 - 2090
  • [37] Emerging Targets and Cellular Therapy for Relapsed Refractory Multiple Myeloma: A Systematic Review
    George, Laeth L.
    Deshpande, Saarang R.
    Cortese, Matthew J.
    Kendall, Ellen K.
    Chattaraj, Asmi
    Shah, Zunairah
    Zhao, Jianjun
    Anwer, Faiz
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (11): : 741 - 751
  • [38] Efficacy of lenalidomide plus dexamethasone in relapsed/refractory multiple myeloma: A systematic review
    Tandy, Fenia
    Hadisurya, Audrey
    Suciningtias, Marlyn
    Chrystelle, Celine
    Kurniawan, Andree
    ANNALS OF ONCOLOGY, 2022, 33 : S489 - S489
  • [39] ECONOMIC AND SOCIAL BURDEN OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA: A SYSTEMATIC REVIEW OF THE LITERATURE
    Casado, L. F.
    Rubio-Rodriguez, D.
    Dias Ferreira, C.
    VALUE IN HEALTH, 2018, 21 : S448 - S448
  • [40] Pomalidomide combined with dexamethasone for the treatment of relapsed/refractory multiple myeloma: a systematic review and meta-analysis
    Luo, Ying
    Li, Chen
    Niu, Yuanchen
    Wu, Shuanzhi
    Tian, Jingyuan
    Hu, Zhiqin
    He, Jin
    Zhang, Zhixin
    Liu, Haiyan
    Li, Yongmei
    Wang, Tenghua
    Fang, Yi
    EXPERT REVIEW OF HEMATOLOGY, 2024, 17 (4-5) : 127 - 134
12345